Legence Corp. <LGN.O>: BMO Raises Target Price to $105 From $100
LGN•Related News
Beneficient FY27 Q1 operating loss narrows 99.4% to $377,000; revenue turns positive to $12.17 million
BENF•
Alphabet's SpaceX bet grows 100-fold over a decade to $94 billion
GOOGL•
Applied Industrial Technologies Inc <AIT.N>: BofA Global Research raises price objective to $390 from $380
AIT•
Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
TVRD•
Matador Resources Chairman, CEO Joseph Foran acquires $778,800 of common shares
MTDR•